Adiposity-Based Chronic Disease (ABCD): A Modern Medical Approach to Excess Body Fat
Obesity is often misunderstood and linked to personal choices or willpower. In reality, changes in body fat and metabolism are shaped by many factors, including biology, hormones, genetics, and overall health.
At LG Endocrinology, we are committed to using clear, evidence-based terminology that reflects the latest medical understanding. One such term is Adiposity-Based Chronic Disease, or ABCD, a clinically grounded framework that recognises excess or dysfunctional body fat (adiposity) as a chronic disease process rather than simply a matter of body weight. This offers a more compassionate and medically informed way of understanding obesity.
Rather than focusing on numbers on a scale, this approach recognises obesity as a chronic medical condition and looks at how body fat affects health and metabolic function. By shifting the focus from blame to understanding, Adiposity-Based Chronic Disease helps reduce stigma and supports a more respectful and supportive healthcare experience, where individuals feel heard and valued. Learn more about Adiposity-Based Chronic Disease below and how this approach can support a healthier, more informed path forward.
What Is Adiposity-Based Chronic Disease?
Adiposity-Based Chronic Disease is a term used in medical literature to describe the complications that arise from excess or dysfunctional fat tissue. Adipose tissue is metabolically active, influencing hormones, inflammation, and energy balance. This explains why people with similar body weights can have very different health risks.
Unlike the traditional label “obesity”, which is often defined solely by Body Mass Index (BMI), Adiposity-Based Chronic Disease is diagnosed by both BMI and the presence of complications and metabolic dysfunction. It focuses on:
- Excess or abnormal fat accumulation
- How adiposity affects metabolic, cardiovascular, and hormonal health
- Related complications such as type 2 diabetes, fatty liver disease, hypertension, dyslipidaemia, sleep apnoea, and certain endocrine disorders
This is why two people with the same weight may have very different health risks.
Why Early Recognition of Adiposity-Based Chronic Disease Matters
In Singapore and around the world, metabolic conditions such as type 2 diabetes, hypertension, and fatty liver disease are highly prevalent. Early identification of adiposity-related complications is crucial to prevent long-term consequences, including cardiovascular disease and endocrine dysfunction.
At LG Endocrinology, we assess more than weight alone. Our evaluation may include:
- Body composition and fat distribution
- Metabolic markers (glucose, lipids and liver enzymes)
- Hormonal assessment
- Cardiovascular risk evaluation
Managing this condition is about supporting your overall well-being, not just focusing on appearance or the numbers on a scale. If you’re concerned, speaking with an endocrinologist is a great first step to get guidance and support on this journey.
Stages of Adiposity-Based Chronic Disease
Adiposity-Based Chronic Disease is classified based on complications and severity, not just weight. These are the different stages:
Stage 0: Increased Risk, No Complications
The earliest stage of ABCD involves these symptoms:
- Elevated body fat
- No metabolic abnormalities
- No obesity-related complications
This stage represents a critical window for prevention. Early lifestyle and medical interventions can help prevent progression.
Stage 1: Mild to Moderate Complications
As ABCD progresses, the complications become more severe, such as:
- Prediabetes
- Mild hypertension
- Borderline cholesterol abnormalities
- Mild fatty liver
- Early joint symptoms
At this stage, structured medical intervention can significantly reduce long-term cardiometabolic risk.
Stage 2: Severe Complications
By this stage, you may experience the following:
- Type 2 diabetes
- Established cardiovascular disease
- Severe sleep apnoea
- Significant fatty liver disease
- Functional impairment
This stage requires comprehensive, multidisciplinary management to address both metabolic health and complications.
Which Factors Contribute to Adiposity-Based Chronic Disease?
Adiposity-Based Chronic Disease develops due to a complex interplay of biological, lifestyle, and environmental factors. Understanding these contributors can help you take proactive steps to reduce risk and manage your health.
Biological and Genetic Factors
Genetics play a significant role in how your body stores fat, regulates appetite, and manages metabolism. Hormonal influences and conditions such as hypothyroidism, Cushing’s syndrome, Polycystic Ovarian Syndrome (PCOS) and insulin resistance can all drive fat accumulation.
Nutrition and Energy Balance
Adiposity-Based Chronic Disease often arises when energy intake consistently exceeds energy expenditure. Diets high in highly processed foods can:
- Increase overall calorie intake
- Disrupt natural satiety signals
- Promote fat accumulation
Moreover, dietary patterns affect not just weight but also the quality of fat and overall metabolic health, highlighting that what you eat matters as much as how much you eat.
Medical Conditions and Medications
Certain medical conditions can make individuals more prone to fat dysfunction and weight gain. These include:
- Endocrine disorders, such as hypothyroidism or adrenal gland disorders, most notably Cushing’s syndrome
- Genetic syndromes affecting metabolism
Some medications may also contribute by:
- Increasing appetite
- Slowing metabolic rate
- Altering fat distribution
Age and Lifestyle Factors
The risk of Adiposity-Based Chronic Disease increases with age due to natural declines in muscle mass and a slower metabolism. Lifestyle factors further compound this risk:
- Inadequate sleep and chronic stress: These factors can disrupt normal hunger signals, leading to increased fat storage.
- Smoking and sedentary habits: These behaviours can contribute to a higher risk of developing Adiposity-Based Chronic Disease.
Physical Activity and Muscle Mass
Low physical activity reduces energy expenditure, accelerates muscle loss, and worsens insulin resistance. Muscle tissue is essential for metabolic health and glucose regulation. This means that regular movement and resistance training are vital in counteracting age-related metabolic decline.
How Is Obesity or Adiposity-Based Chronic Disease Diagnosed?
Adiposity-Based Chronic Disease is diagnosed by looking beyond just weight or body mass index (BMI), and focusing on excess body fat and its impact on health. While BMI can help identify overweight or obesity, a specialist will usually perform a comprehensive evaluation that includes:
- Waist circumference or body composition measurements
- Medical history review to identify obesity-related complications
- Physical examination to assess fat distribution and overall health
- Laboratory tests to check for hormonal imbalances, insulin resistance, or other metabolic factors
This approach allows clinicians to understand not only whether a person has excess adiposity but also how it may affect health and quality of life. If you’re concerned about your weight or metabolic health, book a consultation today to receive a diagnosis tailored to your needs.
How Is Adiposity-Based Chronic Disease Treated?
Adiposity-Based Chronic Disease is a chronic, relapsing condition that requires long-term management. Treatment focuses on improving health outcomes and reducing complications rather than simply targeting BMI. Progress is monitored over time, and therapy is adjusted based on the individual’s response.
Lifestyle and Behavioural Therapy
Lifestyle intervention forms the foundation of Adiposity-Based Chronic Disease treatment at every stage, whether or not medications or surgery are used.
| Lifestyle interventions | How it helps | Strategies |
|---|---|---|
Nutrition therapy | A sustainable, balanced diet is key to managing Adiposity-Based Chronic Disease. The focus is on long-term dietary habits rather than short-term restrictive diets. |
|
Physical activity | Regular physical activity helps improve metabolism, preserve muscle mass, and support overall health. Activity plans should be tailored to your current fitness, mobility, and preferences. |
|
Sleep optimisation | Quality sleep and stress management are essential for metabolic health. Poor sleep and chronic stress can worsen weight regulation and fat metabolism. |
|
Psychological and behavioural support | Mental and emotional health play a crucial role in Adiposity-Based Chronic Disease management. Screening and support help address underlying issues that may impact eating behaviours and lifestyle adherence. |
When necessary, you may be referred to a mental health professional to ensure comprehensive care and long-term support. |
Pharmacologic Therapy
When lifestyle changes alone are insufficient, medications may be used to support health-related goals. These drugs can help control appetite, improve metabolism, and support weight loss. Examples include:
- Incretin-based therapy (GLP-1, e.g., Semaglutide)
- Dual incretin therapy (GLP-1 and GIP, e.g., Tirzepatide)
- Sympathomimetic drugs (e.g., Phentermine)
- Sympathomimetic/antiepileptic combination (e.g., Phentermine/topiramate)
- Lipase inhibitors (e.g., Orlistat)
Medication choice is often guided by evidence of benefit for specific Adiposity-Based Chronic Disease-related complications such as type 2 diabetes, cardiovascular disease, hypertension, chronic kidney disease, obstructive sleep apnea, and osteoarthritis.
Bariatric and Metabolic Surgery
For individuals with moderate to severe Adiposity-Based Chronic Disease that does not respond to lifestyle or medical therapy, bariatric or metabolic surgery may be an effective treatment. Surgical options, such as sleeve gastrectomy or gastric bypass, are considered when other interventions have been insufficient in achieving health improvements.
FAQs About Adiposity-Based Chronic Disease
Why does the Adiposity-Based Chronic Disease Framework matter?
The ABCD framework moves the focus away from weight and stigma, and towards health. Instead of labelling people by numbers, it recognises the biological drivers and medical complexity behind excess adiposity. By framing it as a chronic metabolic condition, not a personal failure, it encourages compassionate, structured, and evidence-based care focused on long-term outcomes.
At LG Endocrinology, this approach translates into respectful, patient-centred care. Management is tailored to the individual, with clear communication, personalised plans, and ongoing support. The goal is not rapid or unsustainable weight loss, but lasting metabolic health and meaningful reduction in long-term risk.
Is Adiposity-Based Chronic Disease just another term for obesity?
Not exactly. While Adiposity-Based Chronic Disease relates to excess body fat, it emphasises:
- The disease nature of dysfunctional adipose tissues
- The presence of medical complications
- A structured, staged approach to treatment
It reframes weight from a cosmetic issue to a chronic medical condition.
If my BMI is high but my blood tests are normal, do I have Adiposity-Based Chronic Disease?
You may be classified as Stage 0 if no complications are present. However, monitoring is important as metabolic risks can evolve over time.
Can someone with a normal BMI have Adiposity-Based Chronic Disease?
Yes. Individuals with a normal BMI but increased visceral fat and metabolic complications may still meet criteria for adiposity-related disease. Waist circumference and metabolic testing are important. It is important to note that BMI may underestimate adiposity and risk among frail or elderly individuals and overestimate adiposity in muscular athletes.
Are medications necessary for everyone with Adiposity-Based Chronic Disease?
No, management depends on
- Stage of disease
- Presence of complications
- Individual response to lifestyle interventions
- Overall medical profile
Medication is considered when clinically appropriate.
What foods cause obesity (Adiposity-Based Chronic Disease)?
Ultra-processed foods are major contributors to obesity and Adiposity-Based Chronic Disease. These are products that are high in calories, added sugars, unhealthy fats, and salt, but low in nutrients.
Regular consumption of ultra-processed foods, such as packaged snacks, sugary drinks, ready-to-eat meals, and fast food, can promote excess fat accumulation, disrupt metabolism, and increase the risk of obesity-related complications. Limiting these foods and focusing on whole, minimally processed options can support better long-term health and weight management.
Is Adiposity-Based Chronic Disease curable?
In the early stages, metabolic abnormalities can improve significantly with appropriate intervention. However, Adiposity-Based Chronic Disease is a chronic condition, and ongoing monitoring and treatment are usually necessary to maintain metabolic stability and prevent relapse.
How can an endocrinologist help with Adiposity-Based Chronic Disease and weight management?
Endocrinologists are specialists in hormones and metabolism, which are key factors in how the body regulates weight. They can assess thyroid function, insulin levels, and other hormonal factors that may contribute to weight gain.
If you have or are concerned about Adiposity-Based Chronic Disease, an endocrinologist like Dr Linsey Gani can assist with assessing your stage of ABCD and the potential hormonal causes. Your doctor will tailor a management plan to optimise your metabolic health, such as medications when needed, ensuring a safe and effective approach to improving overall health.
Book a consultation today to receive expert, medically guided care tailored to your needs.
Disclaimer
This information is provided for general education. It does not replace personalised medical advice. Please consult your doctor for guidance on the medications that may be appropriate for you.
Written by Dr Linsey Gani
Dr Linsey Gani is an endocrinologist experienced in conditions related to hormonal imbalances, including those affecting fertility, menstrual health, and reproductive function. Dr Gani completed her residency in Melbourne, Australia. She is a fellow of the Royal Australian College of physician and the Academy of Medicine, Singapore.
Related Articles
Insulin Pump Singapore: How It Works, Who Should Use It, and Costs
Insulin Pump Singapore: How It Works, Who Should Use It, and Costs Diabetes is common in Singapore, with 9.1% of
What Is Hormonal Acne: Causes, Treatment Methods and Prevention Tips
What Is Hormonal Acne: Causes, Treatment Methods and Prevention Tips Acne is more than just a surface-level skin concern. It
A Guide to GLP-1-Based Medicines for Diabetes and Weight Management in Singapore
A Guide to GLP-1-Based Medicines for Diabetes and Weight Management in Singapore Obesity is a chronic, treatable neurometabolic disease that